ArticleESMO open2022

Reply to: Drug-drug interactions between palbociclib and proton pump inhibitors may significantly affect clinical outcome of metastatic breast cancer patients.

R Beechinor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.